Laurion Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-6,013
| Closed | -$891K | – | 604 |
|
|
2020
Q2 | $891K | Buy |
+6,013
| New | +$891K | 0.01% | 283 |
|
|
2019
Q1 | – | Sell |
-9,341
| Closed | -$681K | – | 549 |
|
|
2018
Q4 | $681K | Buy |
+9,341
| New | +$681K | 0.01% | 304 |
|
|
2018
Q1 | – | Sell |
-121,735
| Closed | -$15.5M | – | 1016 |
|
|
2017
Q4 | $15.5M | Buy |
+121,735
| New | +$15.5M | 0.08% | 78 |
|
|
2017
Q1 | – | Sell |
-9,450
| Closed | -$354K | – | 809 |
|
|
2016
Q4 | $354K | Buy |
+9,450
| New | +$354K | ﹤0.01% | 489 |
|